SOMERSET, N.J. (Map) - SOMERSET, N.J., March 13 /PRNewswire-FirstCall/ -- inVentiv Clinical Solutions, LLC (inVentiv Clinical), a division of inVentiv Health (Nasdaq: VTIV), announced today that they will establish operations in Latin America, a growing region for drug development. The new location will be based in Sao Paulo, Brazil, with the plan to expand operations to other Latin American countries. inVentiv Clinical's Latin American operations will be led by Ana Paula Ruenis, PhD, recently appointed as Director of Clinical Operations, Latin America. Dr. Ruenis is responsible for oversight of project management and monitoring of all Latin American investigative sites for studies conducted by inVentiv Clinical.

Prior to joining inVentiv Clinical,

Dr. Ruenis spent more than eight years in clinical research, representing top US pharmaceutical clients in South America, managing trials in various phases and therapeutic areas from protocol design to site and patient recruitment to final report submission. Dr. Ruenis received both her master's degree and PhD in Pharmacology from the State University of Campinas in Piracicaba, SP, Brazil. She also received training at the Biopharmaceutical Sciences Department of the University of California in San Francisco, CA.

"Having already established full off-shore operations in India, the expansion of our clinical operations into Latin America is an important next step in our goals to become a global clinical services provider," said Mike Hlinak, President and CEO of inVentiv Clinical. He added, "Dr. Ruenis has the expertise and skill to help us build our presence in South America to continue to provide superior quality services to our clients."

About inVentiv Clinical Solutions

inVentiv Clinical Solutions is the premier provider of unique clinical outsourcing solutions, allowing the greatest control and flexibility through unmatched access to high quality clinical resources. As a strategic partner, inVentiv Clinical Solutions provides clinical trial management and monitoring, data management and biostatistics solutions, medical writing, regulatory consulting and liaison services and patient and investigator recruitment. These services are complemented by traditional clinical staffing capabilities through our industry leading staffing divisions, MedFocus and Smith Hanley Consulting Group. For more information, visit www.inventivclinical.com.

About inVentiv Health

inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 325 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.